Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

Once in a while, there’s a topic on the ALS News Today Forums that inspires a new column. The question posted was a simple one: “Do you celebrate ALS-related anniversaries?” I intended my reply to be ...

Life Time's Oct. 25 nationwide fundraiser for ALS research challenges participants to work out for 90 minutes.

It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...

Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.

An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a study reports.

A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.

Building an online store has given columnist Kristin Neva and her husband, Todd, a project to work on together.

Advocates in Canada are urging their federal government to invest more in ALS research and trial opportunities.